News > January > 2013
NHS drug decisions questioned
Researchers claim NHS drug decisions ‘are flawed’ By Jane Dreaper Health correspondent, BBC News The formula used by the NHS to recommend which drugs should be funded is “flawed” and should be scrapped, researchers say. The European Commission-funded study tested the assumptions of the system used by NICE (the National Institute for Health and Clinical…
Public healthcare changes expected in West Wales
A series of controversial proposals to change hospital services in West Wales has been approved by Hywel Dda Health Board. At a special meeting held on Tuesday the board – which covers, Ceredigion, Carmarthenshire and Pembrokeshire – agreed a number of changes based on delivering care closer to people’s own homes and communities, ensuring hospitals…
Finance Wales: Technology venture investments exceed 2012-13 target
Finance Wales’ technology ventures team starts 2013 ahead of target, having completed new and portfolio investments totalling £7 million so far in 2012–13.
Cardiff medical instruments firm Asalus raises £1.25m
MediWales member, Cardiff-based Asalus, has raised £1.25m in a new funding round. In a statement to the London Stock Exchange, Fusion IP – the company that commercialises research from Cardiff University – said that the funds raised by Asalus Medical would be used to complete the manufacture and CE marking of its Ultravision technology, ahead…
Achieving Compliance to ISO 13485 – Barriers to Success & Overcoming them
As a medical device manufacturer, you are no doubt aware that the primary objective of ISO 13485 is to standardise medical device regulatory requirements for quality management systems. ISO 13485 has become the global standard for those who manufacture medical devices because it provides a proven guideline for maintaining assurance and managing risk.
£100m Welsh Life Sciences Fund manager announced
A tender to run the £100m Welsh Life Sciences Fund has been won by new company Arthurian Life Sciences. Documents lodged with Companies House show that the initial share capital in the business – registered last June – is held by Excalibur Fund Managers, which is chaired by biotechnology serial entrepreneur and investor Sir Chris Evans….
Fusion portfolio company, Diurnal, successfully enrols first patient into CATCH Phase 2 trial
Fusion IP, the university commercialisation company which turns university research into business, is pleased to announce that Diurnal has successfully enrolled the first patient into the CATCH trial.
January Member of the Month: Teamwork Technology Services
Teamwork Technology Services (Teamwork ICT) is an established independent provider of ICT (Information Communication Technology) services and consultancy across Wales.
Expert Advice: Welsh Government funding support for businesses in Wales
By Mike Fenwick, Director of Grants, Corporate Finance, Broomfield & Alexander.
UK Lifescience Industry Magazine – Edition 5 out now!
UK Lifescience Industry Magazine – Edition 5 has arrived! UKLSed5 – low res Read a version online here …and you can now follow us on twitter @uklifescience UK Lifescience Industry is the most widely distributed life science publication in the UK, with 39,500 named individuals and an estimated total readership of 100,000 Published by MedilinkUK and its partner organisations, the…